PENNY SOKOL: Open Payments
NPI 1821644568 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 14 payments from 9 companies in 2025. Trend: 2023 $781 · 2024 $399 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC | 3 | $93 |
| Astellas Pharma US Inc | 3 | $66 |
| Biogen, Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $24 |
| Innovation Technologies Inc | 1 | $24 |
| CooperSurgical, Inc. | 1 | $21 |
| Exeltis, USA Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: ACESSA PROVU SYSTEM, Veozah, ZURZUVAE, Dexcom G6 Transmitter, IRRISEPT, NOVASURE, Paragard T 380A, SLYND.
Industry payments across IN — which companies pay providers there.
